Ovarian cancer therapy boosted by drug that could cut chance of dying – study

Ovarian cancer therapy boosted by drug that could cut chance of dying – study (Peter Byrne/PA)

A drug used to treat skin and lung cancers could also cut the chance of dying from a type of ovarian cancer, a new study suggests.

The drug – called trametinib – slowed the progression of cancer and helped boost the number of women responding to treatment.